Yi Chang
Director/Board Member presso NONGFU SPRING CO., LTD.
Posizioni attive di Yi Chang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| NONGFU SPRING CO., LTD. | Director/Board Member | 06/03/2020 | - |
| Independent Dir/Board Member | 06/03/2020 | - | |
| SIPAI HEALTH TECHNOLOGY CO., LTD. | Director/Board Member | 30/07/2021 | - |
| Independent Dir/Board Member | 30/07/2021 | - | |
| COWEALTH MEDICAL CHINA CO.,LTD. | Director/Board Member | 22/03/2019 | - |
| Independent Dir/Board Member | 22/03/2019 | - | |
| China Institute of Internal Audit | Corporate Officer/Principal | - | - |
| Asian Development Bank China | Corporate Officer/Principal | - | - |
| Shanghai Advanced Institute of Finance | Corporate Officer/Principal | 01/07/2018 | - |
| Grant Thornton LLP (China) | Corporate Officer/Principal | - | - |
YishengBio Co., Ltd.
 YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | Director/Board Member | 19/01/2021 | - |
| Independent Dir/Board Member | 19/01/2021 | - |
Storia della carriera di Yi Chang
Precedenti posizioni note di Yi Chang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| YS BIOPHARMA CO., LTD. | Director/Board Member | - | 09/12/2023 |
| Independent Dir/Board Member | - | 09/12/2023 | |
| ░░░░░░░░ ░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░ ░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░░░░ ░░ ░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░ ░░░░ ░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
Formazione di Yi Chang
| University of Missouri | Graduate Degree |
| Texas Tech University | Doctorate Degree |
| National Taiwan University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Cina | 9 |
| Stati Uniti | 5 |
| Isole Cayman | 3 |
Posizioni
| Corporate Officer/Principal | 7 |
| Director/Board Member | 5 |
| Independent Dir/Board Member | 5 |
Settori
| Consumer Services | 5 |
| Health Technology | 4 |
| Consumer Non-Durables | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| NONGFU SPRING CO., LTD. | Consumer Non-Durables |
| SIPAI HEALTH TECHNOLOGY CO., LTD. | Retail Trade |
| COWEALTH MEDICAL CHINA CO.,LTD. | Health Technology |
| YS BIOPHARMA CO., LTD. | Health Technology |
| Aziende private | 7 |
|---|---|
| Texas State Board of Public Accountancy | |
| China Institute of Internal Audit | |
| Ernst & Young (China) | |
Marcum Asia CPAs LLP
 Marcum Asia CPAs LLP Miscellaneous Commercial ServicesCommercial Services Part of Marcum Wealth LLC, Marcum Asia CPAs LLP provides public accounting services. The private company is based in Beijing, China. The CEO of the Chinese company is Enze Liang. | Commercial Services |
| Asian Development Bank China | Government |
| Grant Thornton LLP (China) | |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | Health Technology |
- Borsa valori
- Insiders
- Yi Chang
- Esperienza
